These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 24262679)

  • 1. Imputation of response rates from means and standard deviations in schizophrenia.
    Samara MT; Spineli LM; Furukawa TA; Engel RR; Davis JM; Salanti G; Leucht S
    Schizophr Res; 2013 Dec; 151(1-3):209-14. PubMed ID: 24262679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accounting for uncertainty due to 'last observation carried forward' outcome imputation in a meta-analysis model.
    Dimitrakopoulou V; Efthimiou O; Leucht S; Salanti G
    Stat Med; 2015 Feb; 34(5):742-52. PubMed ID: 25492741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imputing response rates from means and standard deviations in meta-analyses.
    Furukawa TA; Cipriani A; Barbui C; Brambilla P; Watanabe N
    Int Clin Psychopharmacol; 2005 Jan; 20(1):49-52. PubMed ID: 15602117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rounding strategies for multiply imputed binary data.
    Demirtas H
    Biom J; 2009 Aug; 51(4):677-88. PubMed ID: 19650057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imputing missing standard deviations in meta-analyses can provide accurate results.
    Furukawa TA; Barbui C; Cipriani A; Brambilla P; Watanabe N
    J Clin Epidemiol; 2006 Jan; 59(1):7-10. PubMed ID: 16360555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.
    Tandon R; Belmaker RH; Gattaz WF; Lopez-Ibor JJ; Okasha A; Singh B; Stein DJ; Olie JP; Fleischhacker WW; Moeller HJ;
    Schizophr Res; 2008 Mar; 100(1-3):20-38. PubMed ID: 18243663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation of antipsychotic drugs in schizophrenia: a meta-analysis of randomized controlled trials.
    Dold M; Fugger G; Aigner M; Lanzenberger R; Kasper S
    Schizophr Res; 2015 Aug; 166(1-3):187-93. PubMed ID: 26008883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of multiple imputation methods for incomplete longitudinal binary data.
    Yamaguchi Y; Misumi T; Maruo K
    J Biopharm Stat; 2018; 28(4):645-667. PubMed ID: 28886277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dealing with missing data in a multi-question depression scale: a comparison of imputation methods.
    Shrive FM; Stuart H; Quan H; Ghali WA
    BMC Med Res Methodol; 2006 Dec; 6():57. PubMed ID: 17166270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imputation strategies for missing continuous outcomes in cluster randomized trials.
    Taljaard M; Donner A; Klar N
    Biom J; 2008 Jun; 50(3):329-45. PubMed ID: 18537126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing missing outcome data in meta-analysis.
    Mavridis D; Chaimani A; Efthimiou O; Leucht S; Salanti G
    Evid Based Ment Health; 2014 Aug; 17(3):85-9. PubMed ID: 25009175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of several imputation methods for missing baseline data in propensity scores analysis of binary outcome.
    Crowe BJ; Lipkovich IA; Wang O
    Pharm Stat; 2010; 9(4):269-79. PubMed ID: 19718652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian framework to account for uncertainty due to missing binary outcome data in pairwise meta-analysis.
    Turner NL; Dias S; Ades AE; Welton NJ
    Stat Med; 2015 May; 34(12):2062-80. PubMed ID: 25809313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple imputation for longitudinal data in the presence of heteroscedasticity between treatment groups.
    Yamaguchi Y; Ueno M; Maruo K; Gosho M
    J Biopharm Stat; 2020; 30(1):178-196. PubMed ID: 31257987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imputation methods for missing outcome data in meta-analysis of clinical trials.
    Higgins JP; White IR; Wood AM
    Clin Trials; 2008; 5(3):225-39. PubMed ID: 18559412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multiple imputation strategy for sequential multiple assignment randomized trials.
    Shortreed SM; Laber E; Scott Stroup T; Pineau J; Murphy SA
    Stat Med; 2014 Oct; 33(24):4202-14. PubMed ID: 24919867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of temporal kernel canonical correlation analysis in adherence studies.
    John M; Lencz T; Ferbinteanu J; Gallego JA; Robinson DG
    Stat Methods Med Res; 2017 Oct; 26(5):2437-2454. PubMed ID: 26294330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressing findings from meta-analyses of continuous outcomes in terms of risks.
    Anzures-Cabrera J; Sarpatwari A; Higgins JP
    Stat Med; 2011 Nov; 30(25):2967-85. PubMed ID: 21826697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder.
    Siafis S; Rodolico A; Çıray O; Murphy DG; Parellada M; Arango C; Leucht S
    Brain Sci; 2021 Jul; 11(7):. PubMed ID: 34356141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.